Northwire Canada EditionMonday, August 24, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% EML 0.225 −4.3% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% EML 0.225 −4.3%
Financings Routine −

Else Nutrition Announces CSE Conditional Approval

By The Northwire Desk — AI Analysis Jun 29, 2026 · 07:30 BABY · 0.02 ELSE NUTRITION HOLDINGS INC. J
BABY · Price

Executive Summary

  • Else Nutrition Holdings Inc. has received conditional approval to list its common shares on the Canadian Securities Exchange (CSE), with a targeted trading date of July 7, 2026.
  • The listing is contingent upon the completion of a US$310,000 funding round with Lind Global Fund III LP, the settlement of $207,000 in debt via share issuance, and a 10-for-1 share consolidation.
  • The company will settle existing debt by issuing common shares at a post-consolidated price of $0.15 per share as part of the listing requirements.

Key Details

  • Listing Approval: Received conditional approval from the Canadian Securities Exchange (CSE) for common share listing.
  • Target Trading Date: July 7, 2026, subject to final filings, financing completion, debt settlement, and share consolidation.
  • Financing: Working to complete an additional funding of US$310,000 with Lind Global Fund III LP.
  • Share Consolidation: A 10-for-1 share consolidation will be executed (10 existing shares for each 1 new share).
  • Debt Settlement: The Company will settle $207,000 of debt by issuing common shares at a post-consolidated price of $0.15 per share.
  • Listing Conditions: Listing remains subject to CSE approval and satisfaction of customary listing conditions; no assurance that listing will be obtained.
  • Ticker Symbols: TSX: BABY, OTCQX: BABYF, FSE: 0YL.

Notable Quotes

  • No direct quotes from management were included in the provided text.
Read the original news release →

More from ELSE NUTRITION HOLDINGS INC. J

Jun 01, 2026 · 07:45

Else Nutrition Initiates Q2 Manufacturing Drive to Cure Chronic Stockouts as TSX Delisting Looms and CSE Listing Transition Begins

Production / Operations May 15, 2026 · 13:44

Else Nutrition Margins Improve But Liquidity Crunch and TSX Delisting Signal Continued Distress

Earnings May 07, 2026 · 13:55

Distressed Exchange Transition

Regulatory Apr 15, 2026 · 07:30

Else Nutrition Regulatory Wins Fail to Halt Penny Stock Slide Amid Cash Burn Concerns

Regulatory Mar 10, 2026 · 16:36

Else looks to develop potential infant formula in U.S.

Regulatory Mar 10, 2026 · 07:00

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Regulatory